Protagenic Therapeutics (PTIX)

Protagenic Therapeutics (PTIX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.4M; returns 1 day -2.1%, 1 week -4.0%, 1 year -75.9%.

Protagenic Therapeutics (PTIX) is a clinical-stage biopharmaceutical company focused on developing first-in-class neuroactive peptides for stress-related neuropsychiatric and metabolic disorders. As of January 2026, the company operates a pre-revenue business model, with its value entirely driven by its R&D pipeline rather than product sales.

Groups PTIX belongs to

• Biotechnology
• Clinical Stage Biopharma
• Clinical Stage
• Neuroscience
• CNS Disorders
• Metabolic Disorders
• Mental Health Solutions
• Biopharmaceutical
• R&D

PTIX financial model: income statement, cash flow and balance sheet